201 related articles for article (PubMed ID: 11502911)
1. Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy.
Sato Y; Kondo I; Ishida S; Motooka H; Takayama K; Tomita Y; Maeda H; Satoh K
Neurology; 2001 Aug; 57(3):445-9. PubMed ID: 11502911
[TBL] [Abstract][Full Text] [Related]
2. [Effect of carbamazepine and valproate on bone metabolism in children with epilepsy].
Song XQ; Wang ZP; Bao KR; Zhang JM; Wu J; Yan CH; Shen XM
Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):728-32. PubMed ID: 16255847
[TBL] [Abstract][Full Text] [Related]
3. Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy.
Guo CY; Ronen GM; Atkinson SA
Epilepsia; 2001 Sep; 42(9):1141-7. PubMed ID: 11580761
[TBL] [Abstract][Full Text] [Related]
4. The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy.
Heo K; Rhee Y; Lee HW; Lee SA; Shin DJ; Kim WJ; Song HK; Song K; Lee BI
Epilepsia; 2011 Oct; 52(10):1884-9. PubMed ID: 21692779
[TBL] [Abstract][Full Text] [Related]
5. A 12-month longitudinal study of calcium metabolism and bone turnover during valproate monotherapy.
Verrotti A; Agostinelli S; Coppola G; Parisi P; Chiarelli F
Eur J Neurol; 2010 Feb; 17(2):232-7. PubMed ID: 19682062
[TBL] [Abstract][Full Text] [Related]
6. Bone health and vitamin D status in young epilepsy patients on valproate monotherapy.
Albaghdadi O; Alhalabi MS; Alourfi Z; Youssef LA
Clin Neurol Neurosurg; 2016 Jul; 146():52-6. PubMed ID: 27150607
[TBL] [Abstract][Full Text] [Related]
7. Effect of long-term valproate monotherapy on bone mineral density in adults with epilepsy.
Triantafyllou N; Lambrinoudaki I; Armeni E; Evangelopoulos EM; Boufidou F; Antoniou A; Tsivgoulis G
J Neurol Sci; 2010 Mar; 290(1-2):131-4. PubMed ID: 20056251
[TBL] [Abstract][Full Text] [Related]
8. The effects of antiepileptic drugs on the relationships between leptin levels and bone turnover in prepubertal children with epilepsy.
Aksoy A; Sönmez FM; Deger O; Hosver I; Karagüzel G
J Pediatr Endocrinol Metab; 2011; 24(9-10):703-8. PubMed ID: 22145460
[TBL] [Abstract][Full Text] [Related]
9. Effects of valproic acid on bone mineral density and bone metabolism: A meta-analysis.
Fan D; Miao J; Fan X; Wang Q; Sun M
Seizure; 2019 Dec; 73():56-63. PubMed ID: 31756600
[TBL] [Abstract][Full Text] [Related]
10. Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy.
Pack AM; Morrell MJ; Marcus R; Holloway L; Flaster E; Doñe S; Randall A; Seale C; Shane E
Ann Neurol; 2005 Feb; 57(2):252-7. PubMed ID: 15668966
[TBL] [Abstract][Full Text] [Related]
11. The effect of valproate on bone mineral density in adult epileptic patients.
Boluk A; Guzelipek M; Savli H; Temel I; Ozişik HI; Kaygusuz A
Pharmacol Res; 2004 Jul; 50(1):93-7. PubMed ID: 15082034
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral metabolism changes in epileptic children receiving valproic acid.
Oner N; Kaya M; Karasalihoğlu S; Karaca H; Celtik C; Tütüncüler F
J Paediatr Child Health; 2004 Aug; 40(8):470-3. PubMed ID: 15265190
[TBL] [Abstract][Full Text] [Related]
13. Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism.
Nissen-Meyer LS; Svalheim S; Taubøll E; Reppe S; Lekva T; Solberg LB; Melhus G; Reinholt FP; Gjerstad L; Jemtland R
Epilepsia; 2007 Oct; 48(10):1850-60. PubMed ID: 17634065
[TBL] [Abstract][Full Text] [Related]
14. Reduced bone mass and increased bone turnover in postmenopausal women with epilepsy using antiepileptic drug monotherapy.
Lyngstad-Brechan MA; Taubøll E; Nakken KO; Gjerstad L; Godang K; Jemtland R; Bollerslev J
Scand J Clin Lab Invest; 2008; 68(8):759-66. PubMed ID: 18618370
[TBL] [Abstract][Full Text] [Related]
15. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
Zeng K; Wang X; Xi Z; Yan Y
Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
[TBL] [Abstract][Full Text] [Related]
16. Relationship between Bone Density and Biochemical Markers of Bone among Two Groups Taking Carbamazepine and Sodium Valproate for Epilepsy in Comparison with Healthy Individuals in Yazd.
Rahimdel A; Dehghan A; Moghadam MA; Ardekani AM
Electron Physician; 2016 Nov; 8(11):3257-3265. PubMed ID: 28070260
[TBL] [Abstract][Full Text] [Related]
17. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
Katagiri M; Fukunaga M; Ohtawa T; Harada T
World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy.
Tsukahara H; Kimura K; Todoroki Y; Ohshima Y; Hiraoka M; Shigematsu Y; Tsukahara Y; Miura M; Mayumi M
Pediatr Int; 2002 Jun; 44(3):247-53. PubMed ID: 11982890
[TBL] [Abstract][Full Text] [Related]
19. Effects of valproate, lamotrigine, and levetiracetam monotherapy on bone health in newly diagnosed adult patients with epilepsy.
Guo Y; Lin Z; Huang Y; Yu L
Epilepsy Behav; 2020 Dec; 113():107489. PubMed ID: 33220583
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs.
Välimäki MJ; Tiihonen M; Laitinen K; Tähtelä R; Kärkkäinen M; Lamberg-Allardt C; Mäkelä P; Tunninen R
J Bone Miner Res; 1994 May; 9(5):631-7. PubMed ID: 8053391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
